1.A Case of Pumpless Extracorporeal Interventional Lung Assist Application in a Patient with Severe ARDS Who Is Severe Burn with Inhalation Lung Injury: A Case Report.
Chang Min SONG ; Yang hwan CHOI ; Cheon Je YUN ; Yun Cheol JANG
Journal of Korean Burn Society 2012;15(2):131-133
A 35 year old male patient with inhalation injury including 45% body surface area burn was transferred to the hospital. After 2 days of hospitalization lung protective ventilation was supported due to acute respiratory distress occurrence. Fifth day the patient suffered hypercapnea which was uncontrollable with mechanical ventilators. Interventional lung assist (iLA) was proceeded on the tenth day, and the patients hypercapnia symptom was compatible with lung protective ventilation at the time, but the patient eventually suffered death after 12 days of treatment and care in the hospital.
Body Surface Area
;
Burns
;
Hospitalization
;
Humans
;
Hypercapnia
;
Inhalation
;
Lung
;
Male
;
Ventilation
;
Ventilators, Mechanical
2.Pharmacotherapy of Comorbid Disruptive Behavioral Disorders in Children and Adolescents with ADHD.
Je Wook KANG ; Eun Jin PARK ; Seong Chan KIM ; Yee Jin SHIN ; Yun Mi SHIN ; Jaesuk JUNG ; Keun Ah CHEON ; Ki Hwan YOOK
Journal of the Korean Academy of Child and Adolescent Psychiatry 2012;23(Suppl):S55-S65
Disruptive behavioral disorders [oppositional defiant disorder (ODD) and conduct disorder (CD)] are common comorbid disorders in children and adolescents with attention-deficit/hyperactivity disorder (ADHD). ODD/CD may be comorbid up to 60% of children and adolescents with ADHD. Comorbid ODD and CD symptoms can have a significant impact on the course and prognosis of patients with ADHD. Stimulant medications have shown effectiveness in treating both core ADHD symptoms and oppositional symptoms. Assessment and management of comorbid disruptive behavioral symptoms is an essential part in evaluation and treatment of ADHD patients. Further research is needed to investigate the efficacy and safety of various behavioral and medication regimens for ADHD, comorbid ODD and CD and to examine the relationships between ADHD, comorbid ODD and CD.
Adolescent
;
Behavioral Symptoms
;
Child
;
Conduct Disorder
;
Humans
;
Prognosis
3.Pharmacotherapy of Comorbid Disruptive Behavioral Disorders in Children and Adolescents with ADHD.
Je Wook KANG ; Eun Jin PARK ; Seong Chan KIM ; Yee Jin SHIN ; Yun Mi SHIN ; Jaesuk JUNG ; Keun Ah CHEON ; Ki Hwan YOOK
Journal of the Korean Academy of Child and Adolescent Psychiatry 2012;23(Suppl):S55-S65
Disruptive behavioral disorders [oppositional defiant disorder (ODD) and conduct disorder (CD)] are common comorbid disorders in children and adolescents with attention-deficit/hyperactivity disorder (ADHD). ODD/CD may be comorbid up to 60% of children and adolescents with ADHD. Comorbid ODD and CD symptoms can have a significant impact on the course and prognosis of patients with ADHD. Stimulant medications have shown effectiveness in treating both core ADHD symptoms and oppositional symptoms. Assessment and management of comorbid disruptive behavioral symptoms is an essential part in evaluation and treatment of ADHD patients. Further research is needed to investigate the efficacy and safety of various behavioral and medication regimens for ADHD, comorbid ODD and CD and to examine the relationships between ADHD, comorbid ODD and CD.
Adolescent
;
Behavioral Symptoms
;
Child
;
Conduct Disorder
;
Humans
;
Prognosis
4.A Case of Chloroquine-resistant Plasmodium vivax Malaria Imported from Indonesia.
Eun Sil KIM ; Byung Kook NA ; Yun Kyu PARK ; Moon Hyun CHUNG ; Jin Soo LEE ; Seung min CHEON ; Je LEE ; Jeong hun SHIN ; Eun young KIM ; Hyunjoo PAI
Infection and Chemotherapy 2008;40(1):52-57
Resistance of falciparum malaria to antimalarial agents is prevalent in many areas, whereas chloroquine-resistant vivax malaria has been reported mainly around New Guinea since 1989. Concomitant with the spread of chloroquine-resistant P. vivax and increase in number of international travelers, imported cases of chloroquine-resistant vivax malaria in travelers returning from these areas has been reported. We experienced a case of chloroquine resistance P. vivax infection imported from Mangole Island, Indonesia. Its origin is confirmed not to be indigenous by the gene encoding analysis for the polymorphic region of apical membrane antigen-1 in P. vivax. Gene sequencing of the P. vivax mdr1 gene revealed only one substitution located at the codon 1076 (F1076L). The case was managed with oral quinidine with successful outcomes.
Antimalarials
;
Chloroquine
;
Codon
;
Indonesia
;
Malaria
;
Malaria, Vivax
;
Membranes
;
New Guinea
;
Plasmodium
;
Plasmodium vivax
;
Quinidine
5.Two Cases of Streptococcal Toxic Shock Syndrome Caused by Streptococcus agalactiae and Streptococcus dysagalactiae.
Young Sun SUH ; Yun Hong CHEON ; Min Kyo KIM ; Jong Hwa AHN ; Sang Su LEE ; Min Hee LIM ; Byung Hoon KIM ; Sunjoo KIM ; Myung Je CHO ; In Gyu BAE
Infection and Chemotherapy 2011;43(5):429-431
Streptococcal toxic shock syndrome (STSS) is an acute, progressive illness that manifests with fever, hypotension, and accelerated multi-organ failure. It is usually caused by Group A Streptococcus (Streptococcus pyogenes). STSS due to non-group A streptococci is rare, but its incidence has recently increased. We report here on two cases of STSS caused by Group B Streptococcus (Streptococcus agalactiae) and Group G Streptococcus (Streptococcus dysagalactiae).
Fever
;
Hypotension
;
Incidence
;
Shock, Septic
;
Streptococcus
;
Streptococcus agalactiae
6.A Case of Chloroquine-resistant Plasmodium vivax Malaria Imported from Indonesia.
Eun Sil KIM ; Byung Kook NA ; Yun Kyu PARK ; Moon Hyun CHUNG ; Jin Soo LEE ; Seung min CHEON ; Je LEE ; Jeong hun SHIN ; Eun young KIM ; Hyunjoo PAI
Infection and Chemotherapy 2008;40(1):52-57
Resistance of falciparum malaria to antimalarial agents is prevalent in many areas, whereas chloroquine-resistant vivax malaria has been reported mainly around New Guinea since 1989. Concomitant with the spread of chloroquine-resistant P. vivax and increase in number of international travelers, imported cases of chloroquine-resistant vivax malaria in travelers returning from these areas has been reported. We experienced a case of chloroquine resistance P. vivax infection imported from Mangole Island, Indonesia. Its origin is confirmed not to be indigenous by the gene encoding analysis for the polymorphic region of apical membrane antigen-1 in P. vivax. Gene sequencing of the P. vivax mdr1 gene revealed only one substitution located at the codon 1076 (F1076L). The case was managed with oral quinidine with successful outcomes.
Antimalarials
;
Chloroquine
;
Codon
;
Indonesia
;
Malaria
;
Malaria, Vivax
;
Membranes
;
New Guinea
;
Plasmodium
;
Plasmodium vivax
;
Quinidine
7.The Avalibility of C-Arm in Reduction of Zygomatic Arch Fracture Intraoperatively: Case Report
Mi Hyun SEO ; Kang Yong CHEON ; Jun Yong YUN ; Chung Kyu YOO ; Eun Kyung LEE ; Won Deok LEE ; Je Duck SUH
Journal of the Korean Association of Maxillofacial Plastic and Reconstructive Surgeons 2010;32(4):359-362
Chin
;
Facial Bones
;
Orthopedics
;
Palpation
;
Zygoma
8.Clinical Implications of Residual Urine in Korean Benign Prostatic Hyperplasia (BPH) Patients: A Prognostic Factor for BPH-Related Clinical Events.
Young Hwii KO ; Ji Yun CHAE ; Seung Min JEONG ; Jae Il KANG ; Hong Jae AHN ; Hyung Woo KIM ; Sung Gu KANG ; Hoon Ah JANG ; Jun CHEON ; Je Jong KIM ; Jeong Gu LEE
International Neurourology Journal 2010;14(4):238-244
PURPOSE: Although post-void residual urine (PVR) is frequently utilized clinically in patients with benign prostatic hyperplasia (BPH), mainly because of its procedural simplicity, its role as a clinical prognostic factor, predictive of treatment goals, is still under much dispute. We investigated the predictive value of PVR for BPH-related clinical events including surgery, acute urinary retention (AUR), and admission following urinary tract infection (UTI). METHODS: From January to June of 2006, patients over 50 years of age who were diagnosed with BPH for the first time at the outpatient clinic and were then treated for at least 3 years with medications were enrolled in this study. The variables of patients who underwent surgical intervention for BPH, had occurrences of AUR, or required admission due to UTI (Group 1, n=43) were compared with those of patients who were maintained with medications only (Group 2, n=266). RESULTS: Group 1 had a significantly higher PVR, more severe symptoms, and a larger prostate at the time of the initial diagnosis in both the univariate and the multivariate analysis. In the 39 patients who underwent BPH-related surgery, although there was a significant change in Qmax at the time of surgery (mean, 13.1 months), PVR and the symptom score remained unchanged compared with the initial evaluation. In the receiver-operating characteristic curve analysis, the area under the curve of Group 1 was in the order of prostate volume (0.834), PVR (0.712), and symptom score (0.621). When redivided by arbitrarily selected PVR cutoffs of 50 mL, 100 mL, and 150 mL, the relative risk of clinical BPH progression was measured as 3.93, 2.61, and 2.11. CONCLUSIONS: These data indicate that, in the symptomatic Korean population, increased PVR at baseline is a significant indicator of BPH-related clinical events along with increased symptom score or prostate volume.
Ambulatory Care Facilities
;
Disease Progression
;
Dissent and Disputes
;
Humans
;
Multivariate Analysis
;
Prostate
;
Prostatic Hyperplasia
;
Urinary Retention
;
Urinary Tract Infections
9.Cephalometric Evaluation of the Midfacial Soft Tissue Changes on Smiling
Kang Yong CHEON ; Dong Whan SHIN ; Won Bae CHUN ; Soo Ho KIM ; Eu Gene KIM ; Hyong Wook PARK ; Jin Yong CHO ; Jun Yong YUN ; Mi Hyun SEO ; Won Deok LEE ; Je Duck SUH ; Ho LEE
Journal of the Korean Association of Maxillofacial Plastic and Reconstructive Surgeons 2012;34(6):421-425